Ellen Elinck

1.1k total citations
18 papers, 300 citations indexed

About

Ellen Elinck is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Ellen Elinck has authored 18 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Genetics. Recurrent topics in Ellen Elinck's work include Genetics and Neurodevelopmental Disorders (5 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and RNA modifications and cancer (3 papers). Ellen Elinck is often cited by papers focused on Genetics and Neurodevelopmental Disorders (5 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and RNA modifications and cancer (3 papers). Ellen Elinck collaborates with scholars based in Belgium, Netherlands and United Kingdom. Ellen Elinck's co-authors include Ole De Backer, Romain A. Lefebvre, Luc Leybaert, Roberto Motterlini, David Crosiers, Ellen Corsmit, Maria Mattheijssens, Jessie Theuns, Christine Van Broeckhoven and Sebastiaan Engelborghs and has published in prestigious journals such as Gut, Scientific Reports and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Ellen Elinck

15 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen Elinck Belgium 10 154 71 61 50 49 18 300
Thomas Wieser Germany 12 172 1.1× 49 0.7× 44 0.7× 71 1.4× 27 0.6× 19 408
Kentaro Tokudome Japan 11 140 0.9× 49 0.7× 41 0.7× 200 4.0× 25 0.5× 24 390
Flávia Mahatma Schneider Soares Brazil 11 138 0.9× 118 1.7× 52 0.9× 127 2.5× 27 0.6× 12 458
Lisa B. Willing United States 10 115 0.7× 41 0.6× 101 1.7× 68 1.4× 34 0.7× 16 461
Marjo Laitinen Finland 10 146 0.9× 42 0.6× 269 4.4× 64 1.3× 25 0.5× 13 455
K. Sullivan United States 9 84 0.5× 85 1.2× 182 3.0× 86 1.7× 18 0.4× 13 438
Elana R. Lockshin United States 5 172 1.1× 18 0.3× 118 1.9× 27 0.5× 35 0.7× 5 358
Kathia Cordero United States 6 106 0.7× 21 0.3× 117 1.9× 58 1.2× 22 0.4× 7 326
Akira Uto Germany 10 214 1.4× 47 0.7× 52 0.9× 139 2.8× 18 0.4× 13 353
Kimberly N. Hood United States 10 179 1.2× 108 1.5× 37 0.6× 60 1.2× 21 0.4× 16 359

Countries citing papers authored by Ellen Elinck

Since Specialization
Citations

This map shows the geographic impact of Ellen Elinck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Elinck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Elinck more than expected).

Fields of papers citing papers by Ellen Elinck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Elinck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Elinck. The network helps show where Ellen Elinck may publish in the future.

Co-authorship network of co-authors of Ellen Elinck

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Elinck. A scholar is included among the top collaborators of Ellen Elinck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Elinck. Ellen Elinck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cappuyns, Elisa, et al.. (2025). ADNP Exhibits Methyltransferase Activity in Overexpression Systems and Modulates DNA and Histone Methylation. Autism Research. 18(11). 2174–2191.
2.
Dijck, Anke Van, Ellen Elinck, Alexander J.M. Dingemans, et al.. (2025). A frameshift variant in activity-dependent neuroprotective protein (ADNP) causes nucleocytoskeletal alterations in a dizygotic male twin: a case study. Clinical Epigenetics. 17(1). 185–185.
3.
Mateiu, Ligia, et al.. (2025). The ADNP-Mediated Transcriptome Response to Ketamine Impairs the Cytoskeletal Protein Axis. Journal of Molecular Neuroscience. 75(4). 136–136.
4.
Elinck, Ellen, Jasper J. van der Smagt, Mariëlle Alders, et al.. (2024). Loss-of-function of activity-dependent neuroprotective protein (ADNP) by a splice-acceptor site mutation causes Helsmoortel–Van der Aa syndrome. European Journal of Human Genetics. 32(6). 630–638. 4 indexed citations
5.
Dijck, Anke Van, Joe Ibrahim, Ellen Elinck, et al.. (2024). ADNP dysregulates methylation and mitochondrial gene expression in the cerebellum of a Helsmoortel–Van der Aa syndrome autopsy case. Acta Neuropathologica Communications. 12(1). 62–62. 9 indexed citations
6.
Mateiu, Ligia, Ellen Elinck, Michael K. McCormack, et al.. (2024). Identification of a DLG3 stop mutation in the MRX20 family. European Journal of Human Genetics. 32(3). 317–323. 1 indexed citations
7.
Vandeweyer, Geert, Ellen Elinck, Alba Sanchis‐Juan, et al.. (2021). Abundancy of polymorphic CGG repeats in the human genome suggest a broad involvement in neurological disease. Scientific Reports. 11(1). 2515–2515. 18 indexed citations
8.
Dijck, Anke Van, Susana Barbosa, Olfa Khalfallah, et al.. (2020). Reduced serum levels of pro-inflammatory chemokines in fragile X syndrome. BMC Neurology. 20(1). 138–138. 14 indexed citations
9.
Camp, Guy Van, Nils Peeters, Ellen Elinck, et al.. (2018). Bi-allelic inactivating variants in the COCH gene cause autosomal recessive prelingual hearing impairment. European Journal of Human Genetics. 26(4). 587–591. 23 indexed citations
10.
Verstraeten, Aline, David Crosiers, Bram Meeus, et al.. (2012). Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian population. Neurobiology of Aging. 33(8). 1844.e11–1844.e13. 16 indexed citations
11.
Theuns, Jessie, David Crosiers, Luc Debaene, et al.. (2012). Guanosine triphosphate cyclohydrolase 1 promoter deletion causes dopa‐responsive dystonia. Movement Disorders. 27(11). 1451–1456. 8 indexed citations
12.
Meeus, Bram, Aline Verstraeten, David Crosiers, et al.. (2011). DLB and PDD: a role for mutations in dementia and Parkinson disease genes?. Neurobiology of Aging. 33(3). 629.e5–629.e18. 57 indexed citations
13.
Meeus, Bram, Aline Verstraeten, Karen Nuytemans, et al.. (2010). Dementia with Lewy Bodies: A Role for Dementia and Parkinson's Disease Genes?. Movement Disorders. 25. 1 indexed citations
14.
Meeus, Bram, Karen Nuytemans, David Crosiers, et al.. (2010). Comprehensive Genetic and Mutation Analysis of Familial Dementia with Lewy Bodies Linked to 2q35-q36. Journal of Alzheimer s Disease. 20(1). 197–205. 9 indexed citations
15.
Backer, Ole De, et al.. (2009). Peroxisome Proliferator-Activated Receptor γ Activation Alleviates Postoperative Ileus in Mice by Inhibition of Egr-1 Expression and Its Downstream Target Genes. Journal of Pharmacology and Experimental Therapeutics. 331(2). 496–503. 22 indexed citations
16.
Nassauw, Luc Van, Reni Kalfin, Ellen Elinck, et al.. (2008). Jejunal cholinergic, nitrergic, and soluble guanylate cyclase activity in postoperative ileus. Surgery. 144(3). 410–426. 3 indexed citations
17.
Backer, Ole De, Ellen Elinck, Patrick Sips, et al.. (2008). Role of the soluble guanylyl cyclase α1/α2 subunits in the relaxant effect of CO and CORM-2 in murine gastric fundus. Naunyn-Schmiedeberg s Archives of Pharmacology. 378(5). 493–502. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026